FDA Inspection 1160812 — Lifepoint Research, LLP
The FDA completed an inspection of Lifepoint Research, LLP on Jan 14, 2022 in Wakad, Pune. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wakad, Pune (India)
Additional Details
Clinical BA/BE